Benzinga | Nov 9, 2020 04:12PM EST

Neurocrine Biosciences Q3 EPS $0.97 Up From $0.90 YoY, Sales $258.50M Miss $283.04M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.97 per share. This is a 7.78 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $258.50 million which missed the analyst consensus estimate of $283.04 million by 8.67 percent. This is a 16.39 percent increase over sales of $222.09 million the same period last year.